Jared Weiss, MD, explains how the internet can do more harm than good when patients research symptoms before going to see their doctor. He recommends going to see your doctor right when symptoms arise.

July is Sarcoma Awareness Month. Sarcoma is a broad term that refers to over 50 rare cancers that form in the bones or soft tissues of the body. They are rather diverse, too. The cancers can grow in the fat cells, muscles, cartilage, and other connective tissues of the body. Sarcoma can be caused by … Continued

Chad Pecot, MD, associate professor of medicine in the Division of Oncology and member of the UNC Lineberger Comprehensive Cancer Center, will lead the new center dedicated to the investigation of the many roles of RNA in health and disease. The UNC RNA Discovery Center, funded through the UNC Lineberger Comprehensive Cancer Center, will cultivate … Continued

People with advanced cancer who communicated their symptoms weekly using an electronic survey had about a one-third better physical function and over a 15% better control of their symptoms compared to those who were evaluated less frequently via in-person clinical visits, according to findings from a multi-state study conducted at 52 community cancer clinics. The … Continued

A paper published Sunday in the New England Journal of Medicine. For the small study, all 18 patients were given dostarlimab, a checkpoint inhibitor. The results were astounding. Every patient’s cancer disappeared, undetectable by physical examination, endoscopy, PET scans, or M.R.I. scans. Dr. Hanna K. Sanoff, MD, MPH, an associate professor of medicine in the … Continued

Every year, UNC Hospitals conducts the Press Ganey Medical Practice survey to obtain input from patients. Patients are asked if they would refer their provider’s practice to friends and family in the survey. Over the last year, 154 providers within UNC Hospitals received the highest recommendation from more than 89 percent of their patients, putting … Continued

A detailed analysis by researchers at UNC Lineberger Comprehensive Cancer Center and Greensboro Health Disparities Collaborative designed to address racial inequities in timing from diagnosis to surgery for lung cancer found that a  multi-faceted intervention resulted in timelier lung cancer surgery for Black patients. The findings appeared Feb. 14, 2022, in the Journal of Clinical … Continued

Lisa A. Carey, MD, FASCO, the L. Richardson and Marilyn Jacobs Preyer Distinguished Professor for Breast Cancer Research, Division of Oncology and Deputy Director of Clinical Sciences for the Lineberger Comprehensive Cancer Center, discusses findings from a pooled analysis of the MONALEESA-2, -3, and -7 trials. Among the findings was a consistent overall survival benefit with … Continued

UNC researchers working to learn more about omicron variant as 1st case is identified in US – Drs. Melissa Miller and David Wohl (CBS 17) Worried about omicron? COVID’s delta strain remains a bigger threat, UNC doctors say – Drs. Melissa Miller and David Wohl (Charlotte Observer) COVID-19 Mask Recommendations Open New Chapter in Cover … Continued

Behind every photo is a story with the power to uplift and inspire. One year has made all the difference for Frances Lucas from Fayetteville, who was diagnosed with breast cancer in May 2020. And, it was something Dr. Yara Abdou said that set the tone for her journey. “She said, ‘I’m not only going … Continued

Hyman Muss, MD, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology in the Division of Oncology, recently received three research awards. From the Breast Cancer Research Foundation (BCRF), Muss received $190,000 in funding for “p16INK4a Expression, Chemotherapy Toxicity, and Aging in Women with Breast Cancer.” There is significant variability in chemotherapy-related toxicity in women of … Continued

A new study is the first to report the beneficial use of chemotherapy plus immunotherapy before surgical removal of the bladder in muscle-invasive bladder cancer (MIBC). Researchers at the UNC Lineberger Comprehensive Cancer Center led the study, reporting that the regimen reduced the invasiveness of the cancer in 56 percent of patients in a phase … Continued